Larson Financial Group LLC

SEC CIK: 0001731061
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KROS holding history

Keros Therapeutics, Inc. in every 13F filed by Larson Financial Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KROS overview All 13F holders of KROS Full Q2 2026 holdings

Shares (Q2 2026): 5
Value: $54
% of portfolio: <0.1%
Quarters held: 3; Since Q3 2025

Holdings of KROS by Larson Financial Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	5	$54	<0.1%	+5	New	Holders
Q1 2026	0	$0	0.0%	−245−100.0%	Sold out	Holders
Q4 2025	245	$4.99K	<0.1%	−49−16.7%	Reduced	Holders
Q3 2025	294	$4.65K	<0.1%	+294	New	Holders